
Senior Director, Patient Marketing
Who We Are:
Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role:
- Develop and execute a comprehensive U.S. patient marketing strategy across the three indications for bezuclastinib, including unbranded disease awareness and branded campaigns
- Design and implement an integrated digital ecosystem (e.g., websites, search, social, CRM, digital media) that supports education, activation, onboarding, and adherence
- Design a hyper-personalized modular content plan that is unique, relevant, unified, and customized for target audiences
- Develop patient-specific materials, especially for distribution through field teams (e.g., branded patient brochures, treatment initiation kits, and doctor discussion tools)
- Establish foundational metrics/KPIs for patient marketing initiatives pre- and post-launch monitor performance and optimize in real-time
- Lead patient segmentation and journey mapping efforts to inform content strategy and audience targeting across channels
- Collaborate with the patient advocacy team to ensure materials reflect patient needs, voices, and lived experiences
- Lead development of content and execution of patient advisory boards in collaboration with Patient Advocacy
- Partner with market access and HUB teams to build messaging and support tools that address affordability, reimbursement, and treatment continuity
- Consult and collaborate on development of patient support programs and lead creation of resources that enhance engagement and outcomes
- Manage and coordinates the work of agencies of record, multiple external vendors and internal departments including marketing, analytics, operations, legal, regulatory, medical affairs, compliance, and IT
- Align with cross-functional stakeholders, including HCP marketing, medical affairs, patient advocacy, patient services, commercial operations, and legal/regulatory, to ensure consistency and compliance
- Continuously optimize and identify new ways to improve customer engagement and education of disease and product
- Demonstrate leadership with internal teams, specifically with Marketing Leads, Medical Affairs & Market Access to ensure effective, impactful, world-class training on patient directed programs & campaigns to elevate effectiveness of marketing campaigns and share internal best practices
Qualifications:
- Bachelor’s Degree required, MBA or other advanced degree preferred
- Systemic Mastocytosis (or relevant rare disease) preferred (knowledge of current competitive landscape, therapies and practices & patient journey)
- Minimum 8 years of progressive experience in the Pharmaceutical/Biotech industry in Patient Marketing, Marketing, Sales, preferably in both small and large companies
- Demonstrate confidence and comfort in dealing with executive leadership
- 5 years of Brand and/or Patient Marketing specifically with recent in-depth experience in commercialization in the US
- Comfortable engaging with KOLs & Patient Advocacy groups
- Experience as a team/people leader a plus
- Recent (1-3 years) rare disease and/or oncology launch experience strongly preferred
- Demonstrated analytical skills and the ability to think strategically and solve problems
- Outstanding project management skills and experience managing multiple vendors and agency partners and ability to effectively manage multiple competing priorities simultaneously
- Proven track record of working effectively with regulatory, legal and medical teams in approval of promotional materials
- Significant experience in managing budgets including assessing level of investment, tactical planning, budget allocation, timely initiation of projects and billing to keep on track against planned targets
- Some travel required (up to 25%).
- Location: Boston, MA (surrounding areas) required
Salary Range:
250,000 - 290,000 $USD
Apply for this job
*
indicates a required field